Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. C4 Therapeutics Inc’s current trading price is -50.42% away from its 52-week high, while its distance from the 52-week low is 455.66%. The stock’s price range over this period has fluctuated between $1.06 and $11.88. The company, operating within the financial sector, had a trading volume of approximately 0.54 million for the day, which was noticeably lower than the average daily share volume of 1.44 million over the last 3 months.
C4 Therapeutics Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $11.88 on 03/04/24 and the lowest value was $1.06 on 12/06/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
C4 Therapeutics Inc (CCCC) has experienced a quarterly rise of 27.49% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 408.41M and boasts a workforce of 145 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.72, with a change in price of -0.82. Similarly, C4 Therapeutics Inc recorded 1,468,423 in trading volume during the last 100 days, posting a change of -12.22%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CCCC stands at 0.28. Similarly, the long-term debt-to-equity ratio is also 0.25.
CCCC Stock Stochastic Average
Today’s raw stochastic average for C4 Therapeutics Inc over the last 50 days is 47.55%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 50.00%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 58.90% and 61.90%, respectively.
CCCC Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price gain of 4.25% this year. Over the last six months, there has been a stronger performance of -27.91%. The price of CCCC leaped by -7.54% during the last 30 days period. For the last 5-days stocks have slided -7.24%.
